Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome
- 10 August 2006
- journal article
- research article
- Published by Springer Nature in neurogenetics
- Vol. 7 (4) , 247-257
- https://doi.org/10.1007/s10048-006-0054-0
Abstract
Velocardiofacial/DiGeorge syndrome (VCFS/DGS) is a developmental disorder caused by a 1.5 to 3-Mb hemizygous 22q11.2 deletion. VCFS/DGS patients display malformations in multiple systems, as well as an increased frequency of neuropsychiatric defects including schizophrenia. Haploinsufficiency of TBX1 appears to be responsible for these physical malformations in humans and mice, but the genes responsible for the neuropsychiatric defects are unknown. In this study, two mouse models of VCFS/DGS, a deletion mouse model (Lgdel/+) and a single gene model (Tbx1 +/−), as well as a third mouse mutant (Gscl −/−) for a gene within the Lgdel deletion, were tested in a large behavioral battery designed to assess gross physical features, sensorimotor reflexes, motor activity nociception, acoustic startle, sensorimotor gating, and learning and memory. Lgdel/+ mice contain a 1.5-Mb hemizygous deletion of 27 genes in the orthologous region on MMU 16 and present with impairment in sensorimotor gating, grip strength, and nociception. Tbx1 +/− mice were impaired in grip strength similar to Lgdel/+ mice and movement initiation. Gscl −/− mice were not impaired in any of the administered tests, suggesting that redundant function of other Gsc family members may compensate for the loss of Gscl. Thus, although deletion of the genes in the Lgdel region in mice may recapitulate some of the behavioral phenotypes seen in humans with VCFS/DGS, these phenotypes are not found in mice with complete loss of Gscl or in mice with heterozygous loss of Tbx1, suggesting that the neuropsychiatric and physical malformations of VCFS/DGS may act by different genetic mechanisms.Keywords
This publication has 51 references indexed in Scilit:
- Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: Implications for 22q11 deletion syndromeProceedings of the National Academy of Sciences, 2006
- Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosageHuman Molecular Genetics, 2004
- Neurobiology of Pavlovian Fear ConditioningAnnual Review of Neuroscience, 2001
- The 22q11 deletion syndromesHuman Molecular Genetics, 2000
- Emotion Circuits in the BrainAnnual Review of Neuroscience, 2000
- Congenital heart disease in mice deficient for the DiGeorge syndrome regionNature, 1999
- Correlation between Loss of Middle Ear Bones and AlteredgoosecoidGene Expression in the Branchial Region Following Retinoic Acid Treatment of Mouse Embryosin VivoBiochemical and Biophysical Research Communications, 1997
- Follow‐up of a report of a potential linkage for schizophrenia on chromosome 22q12‐q13.1: Part 2American Journal of Medical Genetics, 1994
- Familial third-fourth pharyngeal pouch syndrome with apparent autosomal dominant transmissionThe Journal of Pediatrics, 1984
- The spectrum of the DiGeorge syndromeThe Journal of Pediatrics, 1979